Leqembi approved as first treatment to slow early Alzheimer’s progression - PharmaTimes European Commission grants authorisation for Eisai and Biogen therapy

#neurology #Leqembi #lecanemab #Alzheimerstreatment #Eisai #Biogen #earlyAlzheimersdisease #mildcognitiveimpairment #milddementia #Alzheimers #apolipoproteinEε4noncarriers #amyloidpathology #ClarityADtrial #amyloidbetaprotofibrils #cognitivedecline
pharmatimes.com/news/leqembi...